Concepedia
Statistics
Publications
76
Citations
4.2K
H-Index
36
Active since
1991
Affiliations
Sanofi (Germany)(Current)
Sanofi (France)
Technical University of Munich
LETI Pharma (Germany)
Hans Matter is an author at Sanofi (Germany) specializing in medicine, drug discovery, and pharmacology.
Top concepts
MedicineDrug DiscoveryPharmacologyNatural SciencesBiochemistryMedicinal ChemistryChemical BiologyMolecular BiologyMolecular DockingEngineering
Publications per year
1991–2023
Targeting DnaN for tuberculosis therapy using novel griselimycins
Angela Kling, Peer Lukat, Deepak V. Almeida et al. · Science · 2015 · 309 citations
Streptomyces-produced Streptomycin, Antibiotic Adjuvant, Tuberculosis Prevention +18
Evidence for CCl/CBr⋅⋅⋅π Interactions as an Important Contribution to Protein–Ligand Binding Affinity
Hans Matter, Marc Nazaré, Stefan Güssregen et al. · Angewandte Chemie International Edition · 2009 · 267 citations
Selecting Optimally Diverse Compounds from Structure Databases: A Validation Study of Two-Dimensional and Three-Dimensional Molecular Descriptors
Hans Matter · Journal of Medicinal Chemistry · 1997 · 251 citations
Topological Similarity, Molecular Biology, Chemistry +21
Predictive Multitask Deep Neural Network Models for ADME-Tox Properties: Learning from Large Data Sets
Jan Wenzel, Hans Matter, Friedemann Schmidt · Journal of Chemical Information and Modeling · 2019 · 209 citations
Virtual Screening of Biogenic Amine-Binding G-Protein Coupled Receptors: Comparative Evaluation of Protein- and Ligand-Based Virtual Screening Protocols
Andreas Evers, Hans Matter, Thomas Klabunde · Journal of Medicinal Chemistry · 2005 · 182 citations
1–5 of 76